Mesenchymal stem cell secretome: A promising therapeutic strategy for erectile dysfunction?

Area of Science:

• Regenerative Medicine
• Urology
• Cell Biology

Background:

• Mesenchymal stem cells (MSCs) release bioactive compounds known as the secretome.
• The MSC secretome has therapeutic potential in regenerative medicine.
• Erectile dysfunction (ED) is a condition with ongoing research into novel treatments.

Purpose of the Study:

• To explore the therapeutic potential of the MSC secretome in regenerative urology for ED.
• To review preclinical and clinical research on MSCs and their secretome in ED treatment.
• To highlight the rationale, mechanisms, and potential of the MSC secretome for ED.

Main Methods:

• Comprehensive literature review of preclinical and clinical studies on MSCs and ED.
• Analysis of existing knowledge on MSC secretome's therapeutic properties.
• Examination of underlying processes for therapeutic efficacy.

Main Results:

• Preclinical research demonstrates MSC secretome effectiveness in ED models.
• The MSC secretome exhibits anti-inflammatory, pro-angiogenic, and trophic properties.
• Potential advantages include reduced immunogenicity, neoplastic transformation, and cost compared to cell therapy.

Conclusions:

• The MSC secretome holds significant therapeutic promise for ED in regenerative urology.
• Further research is crucial to elucidate specific mechanisms before clinical application.
• Challenges in clinical translation and future perspectives are discussed.